Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Impact of cost of medicines for chronic conditions on low income households in Australia

    Access Status
    Fulltext not available
    Authors
    Kemp, A.
    Preen, D.
    Glover, J.
    Semmens, James
    Roughead, E.
    Date
    2013
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Kemp, Anna. and Preen, David B. and Glover, John and Semmens, James and Roughead, Elizabeth E. 2013. Impact of cost of medicines for chronic conditions on low income households in Australia. Journal of Health Services Research & Policy. 18 (1): pp. 21-27.
    Source Title
    Journal of Health Services Research & Policy
    Additional URLs
    http://jhsrp.rsmjournals.com/content/18/1/21.full.pdf
    ISSN
    1355-8196
    URI
    http://hdl.handle.net/20.500.11937/30314
    Collection
    • Curtin Research Publications
    Abstract

    Objectives: To determine the cost of medicines for selected chronic illnesses and the proportion of discretionary income this would potentially displace for households with different pharmaceutical subsidy entitlements and incomes. Methods: We analysed household income and expenditure data for 9,774 households participating in two Australian surveys in 2009–10. The amount of ‘discretionary’ income available to households after basic living and health care expenditure was modelled for households with high pharmaceutical subsidies: pensioner and non-pensioner concessional (social security entitlements); and households with general pharmaceutical subsidies and low, middle or high incomes. We calculated the proportion of discretionary income that would be needed for medicines if one household member had diabetes or acute coronary syndrome, or if one member also had two co-existing illnesses (gastro-oesophageal reflux disease and depression, or asthma and osteoarthritis).Results: Pensioner and low income households had little discretionary income after basic living and health care expenditure (AUD$92 and $164/week, respectively). Medicines for the specified illnesses ranged from $11–$42/month for high subsidy households and $34–$186/month for low subsidy households. Costs reduced substantially once patients reached the annual pharmaceutical cap (safety net), prior to which medicine costs would displace the equivalent of 1%–10% of discretionary income for most household types. However, low income households would have to forego the equivalent of between 5%–26% of their discretionary income for between 7 and 9 months of the year before receiving additional subsidies. Conclusions: Prescription medicines for chronic conditions pose a substantial financial burden to many households, particularly those with low incomes and general pharmaceutical subsidies. Policies are needed to minimize the cost burden of prescription medicines, particularly for low-income working households.

    Related items

    Showing items related by title, author, creator and subject.

    • The impact of dispensing fees on compliance with opioid substitution therapy: a mixed methods study
      Shepherd, A.; Perrella, B.; Hattingh, H. Laetitia (2014)
      Background: Opioid substitution therapy (OST) programs involve the dispensing of OST medicines to patients to address their dependence on heroin and/or other opioid substances. OST medicines are subsidised by the Australian ...
    • Transport disadvantage and low-income rental housing
      Burke, T.; Stone, J.; Glackin, S.; Scheurer, Jan (2014)
      Despite the plethora of rental research, a significant gap remains in understanding the relationship between rental housing and 'transport disadvantage'. This project analyses the changing spatial concentration of ...
    • Evaluating pharmaceutical policy impacts using interrupted time series analysis: An Australian case study
      Kemp, A.; Preen, D.; Sanfilippo, F.; Glover, J.; Semmens, James; Roughead, E. (2011)
      Determining the impacts of policy on health outcomes is important for policy makers, clinicians and consumers. Interrupted time series analysis is a powerful quasi-experimental method for quantifying change in an outcome ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.